Senores Pharms Company Profile
✉ Email this page to a colleague
What is the competitive landscape for SENORES PHARMS, and what generic and branded alternatives to SENORES PHARMS drugs are available?
SENORES PHARMS has thirteen approved drugs.
Drugs and US Patents for Senores Pharms
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Senores Pharms | BUTALBITAL AND ACETAMINOPHEN | acetaminophen; butalbital | TABLET;ORAL | 214088-001 | Apr 7, 2022 | AA | RX | No | No | ⤷ Subscribe | ⤷ Subscribe | ||||
Senores Pharms | AMPHETAMINE SULFATE | amphetamine sulfate | TABLET;ORAL | 212901-002 | May 22, 2020 | AA | RX | No | No | ⤷ Subscribe | ⤷ Subscribe | ||||
Senores Pharms | TOPIRAMATE | topiramate | CAPSULE;ORAL | 218642-002 | Oct 10, 2024 | AB | RX | No | No | ⤷ Subscribe | ⤷ Subscribe | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Similar Applicant Names
Here is a list of applicants with similar names.